50 results
SC TO-T
EX-99
CTIC
CTI BioPharma Corp
25 May 23
Third party tender offer statement
6:46am
disaster, acts of god, epidemic, pandemic, national or international calamity or any other similar event, including an outbreak or escalation of hostilities
SC14D9C
EX-2.1
CTIC
CTI BioPharma Corp
10 May 23
Written communication relating to third party tender offer
1:30pm
or international calamity, natural or manmade disaster, acts of god, epidemic, pandemic, national or international calamity or any other similar event, including
8-K
EX-2.1
CTIC
CTI BioPharma Corp
10 May 23
Tender and Support Agreement
8:05am
or international calamity, natural or manmade disaster, acts of god, epidemic, pandemic, national or international calamity or any other similar event, including
8-K
EX-99.1
f1mrz 2eqx8se2xcxh3
7 Nov 22
CTI BioPharma Reports Third Quarter 2022 Financial Results
4:07pm
8-K
EX-99.1
sc2zezux
28 Sep 22
Other Events
4:05pm
8-K
EX-99.1
x7f54 rp9aj
8 Aug 22
CTI BioPharma Reports Second Quarter 2022 Financial Results
4:08pm
8-K
EX-99.1
0utwdwanw
12 May 22
CTI BioPharma Reports First Quarter 2022 Financial Results
4:07pm
8-K
EX-99.1
bwj9s89v93k3rny9zu
31 Mar 22
CTI BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results
4:04pm
8-K
EX-99.1
6dua1efh49r8xm5 5gjb
1 Mar 22
CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia
8:02pm
8-K
EX-99.1
xuhfs lf2gfl
24 Aug 21
CTI BioPharma Announces Appointment of Diane Parks to Its Board of Directors
9:42pm
8-K
EX-99.1
wbuecfmyoj5cn40 bmrf
5 Aug 21
CTI BioPharma Reports Second Quarter 2021 Financial Results
4:10pm
8-K
EX-99.1
aueca wmye
1 Jun 21
CTI BioPharma Reports First Quarter 2021 Financial Results
4:09pm